Semaglutide’s Minimal Impact on Muscle Mass and Strength in American Males: A Longitudinal Study
Reading Time: 2 minutes Introduction Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has gained significant attention for its role in managing type 2 diabetes and obesity. While its efficacy in weight management is well-documented, concerns have been raised about its potential effects on muscle mass and strength, particularly in American males. This article explores the longitudinal study findings on semaglutide's influence on muscle mass and strength, providing valuable insights for healthcare providers and patients. Study Design and Methodology The longitudinal study involved a cohort of American males aged 30 to 65 years, diagnosed with obesity or type 2 diabetes. Participants were administered semaglutide weekly...


